Peripheral Blood Stem Cell TransplantationBone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell MobilizationBone MarrowGraft vs Host DiseaseGranulocyte Colony-Stimulating FactorLeukapheresisBone Marrow CellsHematopoietic Stem CellsTransplantation ConditioningBlood Component RemovalHematologic NeoplasmsAntigens, CD34Graft SurvivalStem CellsTissue DonorsCyclophosphamideCombined Modality TherapyMelphalanWhole-Body IrradiationLeukemiaTreatment OutcomeBlood CellsBusulfanAnemia, AplasticHistocompatibility TestingImmunosuppressive AgentsMultiple MyelomaHistocompatibilityAntineoplastic Combined Chemotherapy ProtocolsRecurrenceCytomegalovirus InfectionsHematopoiesisLymphoma, Non-HodgkinLeukocytes, MononuclearTransplantation ChimeraBlood Cell CountTime FactorsBone Marrow PurgingStem Cell TransplantationCord Blood Stem Cell TransplantationRetrospective StudiesBone Marrow DiseasesMyeloablative AgonistsLeukemia, Myeloid, AcuteT-LymphocytesEtoposideRemission InductionFlow CytometryImmunosuppressionKidney TransplantationThiotepaCyclosporineLeukocyte CountTransplantation, IsogeneicLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSurvival AnalysisDisease-Free SurvivalColony-Forming Units AssayOpportunistic InfectionsAntineoplastic Agents, AlkylatingInfectionSurvival RateImmunophenotypingLymphocytesPlatelet CountCell SeparationLymphocyte DepletionGraft RejectionCells, CulturedBlood DonorsAcute DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaHodgkin DiseaseImmunocompromised HostHematologic DiseasesHLA AntigensAntigens, CDMyelodysplastic SyndromesRecombinant ProteinsCytarabineCytomegalovirusBlood Group IncompatibilityPolymerase Chain ReactionFatal OutcomeNuclear FamilyLymphomaSalvage TherapyFollow-Up StudiesLeukocyte TransfusionIfosfamideAntilymphocyte SerumNeoplasmsTransplantsGranulocytesImmunomagnetic SeparationProspective Studies